期刊文献+

PTTG和MMP-9蛋白表达在食管癌临床分期中的价值 被引量:1

Value of Protein Expression PTTG and MMP-9 with Clinical Stage of Esophageal Carcinoma
下载PDF
导出
摘要 目的研究PTTG和MMP-9在食管癌中的表达及其相关性,探讨它们对食管癌临床分期的价值。方法应用免疫组织化学SP法检测84例食管癌组织中PTTG和MMP-9蛋白表达,结合临床病理参数并将其纳入食管癌临床分期进行预后分析。结果 PTTG和MMP-9在食管癌组织中均呈阳性表达,且两者表达呈正相关。PTTG、MMP-9蛋白在食管癌临床分期较晚的患者中阳性表达率明显高于临床分期早的患者。结论 PTTG和MMP-9蛋白在食管癌组织中呈高表达,且与食管癌临床分期显著正相关,提示两者在食管癌发生、发展及侵袭转移过程中可能起重要作用。 Objective To explore the function of PTTG and MMP-9 protein expression and evaluate their relationship with clinical stage of esophageal carcinoma. Methods Immunohistochemistry SP was used to check the protein expression of PTTG and MMP-9 in biopsy tissue specimen of 84 cases esophageal carcinoma, and the relationship between protein expression level and clinical stage grades was analyzed. Results PTTG and MMP-9 protein were high expression and with positive correlation in esophageal carcinoma. Positive expression rate were higher in late clinical stage than that in early stage in esophageal carcinoma. Conclusion PTTG and MMP-9 are high expression,and the two sorts of protein expression have a positive correlation with clinical stage of esophageal carcinoma. It suggests that PTTG and MMP-9 genes play an important role in regulating occurre,development,invasion and metastasis of esophageal carcinoma.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第10期1243-1245,共3页 Cancer Research on Prevention and Treatment
关键词 食管癌 临床分期 垂体瘤转化基因 基质水解蛋白酶-9 预后 Esophageal carcinoma Clinical Staging PTTG MMP-9 Prognosis
  • 相关文献

参考文献3

二级参考文献19

  • 1祝淑钗,李任,李娟,邱嵘,韩春,万钧.非手术治疗胸段食管癌临床分期与预后关系的初步探讨[J].中华放射肿瘤学杂志,2004,13(3):189-192. 被引量:70
  • 2丛佳,汪洪毅.垂体瘤转化基因(PTTG)的研究进展[J].肿瘤防治研究,2005,32(8):522-524. 被引量:4
  • 3Yu R, Melmed S. Pituitary tumor transforming gene: an update [J]. Front Horm Res, 2004,32(1) :175-178.
  • 4Robson S, Pelengaris S, Khan M, et al. c- myc and downstream targets in the pathogenesis and treatment of cancer [J]. Recent Patents Anticancer Drug Discov, 2006 , 1 (3): 305-326.
  • 5Bradshaw C, Kakar SS. Pituitary tumor transforming gene:an important gene in normal cellular functions and tumorigenesis[J]. Histol Histopathol, 2007, 22(2):219-226.
  • 6Donangelo I, Melmed S, Solbach C, et al. Pituitary tumortransforming gene (PTTG): a novel target for anti-tumor therapy[J]. Anticancer Res, 2005,25 (1) : 121-125.
  • 7Stella Pel, Mike Kh, Gerard E, et al. c-myc: More than just a matter of life and death[J]. Nature Reviews Cancer, 2002,904 (2) : 764-776.
  • 8Pei L. Identification of c-myc as a down-stream target for pituitary tumor transforming gene[J]. J Biol Chem, 2001, 276 (11): 8484-8491.
  • 9Boelaert K,Yu R, Tannahill LA, et al. PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro[J]. J Mol Endocrinol,2004,33 (3): 663-677.
  • 10Clem AL, Hamid T, Kakar SS. Characterization of the role of Spl and NF-Y in differential regulation of PTTG/securin expression in tumor cells[J]. Gene, 2003,322(2) : 113-121.

共引文献16

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部